Everolimus in ileum neuroendocrine tumours - Authors' reply

Lancet. 2016 Jul 16;388(10041):236-7. doi: 10.1016/S0140-6736(16)31045-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Everolimus / therapeutic use*
  • Female
  • Gastrointestinal Neoplasms / drug therapy*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Neuroendocrine Tumors / drug therapy*
  • Neuroendocrine Tumors / mortality*

Substances

  • Antineoplastic Agents
  • Everolimus